Class II · Moderate risk
All hydroxyzine Products
Lack of Processing Controls
FDA Drug Recalls
18,003 recalls, newest first
Class II · Moderate risk
All budesonide Products
Lack of Processing Controls
Class II · Moderate risk
All cetirizine Products
Lack of Processing Controls
Class II · Moderate risk
All arginine Products
Lack of Processing Controls
Class II · Moderate risk
All T4-levothyroxine Products
Lack of Processing Controls
Class II · Moderate risk
All thymol Products
Lack of Processing Controls
Class II · Moderate risk
All PCCA Lipoderm Products
Lack of Processing Controls
Class II · Moderate risk
All tetracaine Products
Lack of Processing Controls
Class II · Moderate risk
All propylparaben Products
Lack of Processing Controls
Class II · Moderate risk
All methimazole Products
Lack of Processing Controls
Class II · Moderate risk
All fluocinonide Products
Lack of Processing Controls
Class II · Moderate risk
All Germall
Lack of Processing Controls
Class II · Moderate risk
All betamethasone diproprionate Products
Lack of Processing Controls
Class II · Moderate risk
All monobenzone Products
Lack of Processing Controls
Class II · Moderate risk
All carbomer Products
Lack of Processing Controls
Class II · Moderate risk
All progesterone Products
Lack of Processing Controls
Class II · Moderate risk
All Peterson Cream Products
Lack of Processing Controls
Class II · Moderate risk
All TRIE Products
Lack of Processing Controls
Class II · Moderate risk
All estriol Products
Lack of Processing Controls
Class II · Moderate risk
All testosterone Products
Lack of Processing Controls
Class I · High risk
Cap-Biotin 100 Mg
Labeling: Label Mix-Up: Products labeled Biotin 100 mg found to contain 4-aminopyridine
Class II · Moderate risk
All 4-aminopyridine Products
Lack of Processing Controls
Class III · Low risk
Venlafaxine 75 mg Tablet
Labeling: Label Mix-Up: Bryant Ranch received Tevas venlafaxine hydrochloride extended-release tablets for repackaging, but labeled it incorrectly as the immediate release formulation.
Class I · High risk
5% Dextrose Injection USP
Non-Sterility: fungal contamination due to leaking containers.
Class III · Low risk
Escitalopram Tablets USP 20 mg
Labeling: Incorrect or Missing Lot and/or Expiration Date